(S)-Chroman-4-amine is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its chiral structure makes it valuable for developing enantiomerically pure drugs, particularly those targeting the central nervous system. It is often employed in the production of serotonin and norepinephrine reuptake inhibitors (SNRIs), which are used to treat depression, anxiety, and chronic pain disorders. Additionally, its scaffold is explored in the design of compounds with potential antioxidant and neuroprotective properties, making it relevant in research focused on neurodegenerative diseases like Alzheimer's and Parkinson's. The compound's versatility also extends to its use in organic synthesis for constructing complex molecules with therapeutic potential.